Chaoju Eye Care Holdings Ltd
Chaoju Eye Care Holdings Ltd provides eye care services and products, including optometry, eyewear, and vision correction solutions, primarily in China.
Business. Chaoju Eye Care Holdings Ltd (2219.HK) is a healthcare services company listed on the Hong Kong Stock Exchange. The firm operates within the healthcare facilities and services industry, generating revenue primarily through service-based models. Specific details regarding its operating segments, headquarters location, and geographic presence are not provided in the available data.
At a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
Chaoju Eye Care Holdings Ltd (2219.HK) is a healthcare services company listed on the Hong Kong Stock Exchange. The firm operates within the healthcare facilities and services industry, generating revenue primarily through service-based models. Specific details regarding its operating segments, headquarters location, and geographic presence are not provided in the available data.
Chaoju Eye Care's capital structure is characterized by a lack of detailed liquidity metrics, as no balance-sheet inputs are available and no going-concern language is present in source documents. This limits the ability to assess short-term liquidity risk.
Profitability metrics are not available in the valuation snapshot, and no industry-specific preferred metrics are provided in the industry configuration. Without comparative data, it is not possible to assess Chaoju Eye Care's profitability relative to its peers.
The company's revenue is concentrated in a single geographic market, China, with no disclosed segment breakdown. This concentration increases exposure to local economic and regulatory shifts.
Growth trajectory is not quantifiable due to the absence of historical revenue data and forward-looking guidance. Analysts have provided a uniform price target of 3.90 CNY, but no revenue growth estimates are available.
Risk factors include the inability to assess liquidity risk and the lack of detailed financial disclosures. Dilution risk is currently low, as there is no evidence of dilutive events in the near term.
Recent events include the publication of analyst price targets, all of which are identical at 3.90 CNY. No recent filings or transcripts have been disclosed that provide additional insight into the company's operations or strategy.
- Chaoju Eye Care operates in the eye care services and products market in China.
- The company's classification is well-supported by verified market data.
- Liquidity and profitability metrics are not available, limiting the ability to assess financial health.
- Revenue is concentrated in a single geographic market, increasing exposure to local risks.
- Analysts have provided a uniform price target, but no detailed growth or risk analysis is available.
Bull / Bear case
Generated · model-assistedIn focus — financials by report
Revenue ¥1.36B, −3,2% YoY; Operating income −1,9% YoY.
- ▍Revenue ¥1.36B, −3,2% YoY
- ▍Operating income −1,9% YoY
- ▍Net income −6,0% YoY
- ▍Free cash flow +136,0% YoY
- ▍Net margin 13.5%
Revenue ¥1.37B, +38,3% YoY; Operating income +24,1% YoY.
- ▍Revenue ¥1.37B, +38,3% YoY
- ▍Operating income +24,1% YoY
- ▍Net income +21,9% YoY
- ▍Free cash flow +56,0% YoY
- ▍Net margin 16.7%
Revenue ¥990.0M, −0,8% YoY; Operating income +13,5% YoY.
- ▍Revenue ¥990.0M, −0,8% YoY
- ▍Operating income +13,5% YoY
- ▍Net income +16,1% YoY
- ▍Free cash flow +39,4% YoY
- ▍Net margin 19.0%
Revenue ¥997.8M; Operating income ¥221.1M.
- ▍Revenue ¥997.8M
- ▍Operating income ¥221.1M
- ▍Net margin 16.2%
Valuation FY
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
Options
Short squeeze
Earnings-call key lines
Consensus distribution
sell-side coverageEstimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Chaoju Eye Care Holdings Ltd Market data — financials · 2026-05-26
- Chaoju Eye Care Holdings Ltd Market data — analyst estimates · 2026-05-26